BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 1314890)

  • 1. Treatment of recurrent gliomas and metastatic brain tumors with a polydrug protocol designed to combat nitrosourea resistance.
    Levin VA; Prados MD
    J Clin Oncol; 1992 May; 10(5):766-71. PubMed ID: 1314890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TPDC-FuHu chemotherapy for the treatment of recurrent metastatic brain tumors.
    Kaba SE; Kyritsis AP; Hess K; Yung WK; Mercier R; Dakhil S; Jaeckle KA; Levin VA
    J Clin Oncol; 1997 Mar; 15(3):1063-70. PubMed ID: 9060546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of 6-thioguanine, procarbazine, lomustine, and hydroxyurea for patients with recurrent malignant gliomas.
    Kyritsis AP; Yung WK; Jaeckle KA; Bruner J; Gleason MJ; Ictech SE; Flowers A; Levin VA
    Neurosurgery; 1996 Nov; 39(5):921-6. PubMed ID: 8905746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II study of 6-thioguanine, procarbazine, dibromodulcitol, lomustine, and vincristine chemotherapy with radiotherapy for treating malignant glioma in children.
    Levin VA; Lamborn K; Wara W; Davis R; Edwards M; Rabbitt J; Malec M; Prados MD
    Neuro Oncol; 2000 Jan; 2(1):22-8. PubMed ID: 11302250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of high-risk medulloblastoma and other primitive neuroectodermal tumors with reduced dose craniospinal radiation therapy and multi-agent nitrosourea-based chemotherapy.
    Prados MD; Wara W; Edwards MS; Ater J; Rabbit J; Lamborn K; Davis R; Levin VA
    Pediatr Neurosurg; 1996 Oct; 25(4):174-81. PubMed ID: 9293544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of chiasmal and hypothalamic gliomas of infancy and childhood with chemotherapy.
    Petronio J; Edwards MS; Prados M; Freyberger S; Rabbitt J; Silver P; Levin VA
    J Neurosurg; 1991 May; 74(5):701-8. PubMed ID: 1901597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiation therapy and hydroxyurea followed by the combination of 6-thioguanine and BCNU for the treatment of primary malignant brain tumors.
    Prados MD; Larson DA; Lamborn K; McDermott MW; Sneed PK; Wara WM; Chang SM; Mack EE; Krouwer HG; Chandler KL; Warnick RE; Davis RL; Rabbitt JE; Malec M; Levin VA; Gutin PH; Phillips TL; Wilson CB
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):57-63. PubMed ID: 9422558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of recurrent brain stem gliomas and other central nervous system tumors with 5-fluorouracil, CCNU, hydroxyurea, and 6-mercaptopurine.
    Rodriguez LA; Prados M; Fulton D; Edwards MS; Silver P; Levin V
    Neurosurgery; 1988 Apr; 22(4):691-3. PubMed ID: 3374780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme.
    Levin VA; Uhm JH; Jaeckle KA; Choucair A; Flynn PJ; Yung WKA ; Prados MD; Bruner JM; Chang SM; Kyritsis AP; Gleason MJ; Hess KR
    Clin Cancer Res; 2000 Oct; 6(10):3878-84. PubMed ID: 11051233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multimodality management of recurrent adult malignant gliomas: results of a phase II multiagent chemotherapy study and analysis of cytoreductive surgery.
    Rostomily RC; Spence AM; Duong D; McCormick K; Bland M; Berger MS
    Neurosurgery; 1994 Sep; 35(3):378-88; discussion 388. PubMed ID: 7800129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase III comparison of BCNU and the combination of procarbazine, CCNU, and vincristine administered after radiotherapy with hydroxyurea for malignant gliomas.
    Levin VA; Wara WM; Davis RL; Vestnys P; Resser KJ; Yatsko K; Nutik S; Gutin PH; Wilson CB
    J Neurosurg; 1985 Aug; 63(2):218-23. PubMed ID: 2991486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II study of combined carmustine, 5-fluorouracil, hydroxyurea, and 6-mercaptopurine (BFHM) for the treatment of malignant gliomas.
    Levin VA; Phuphanich S; Liu HC; Da Silva V; Murovic J; Choucair A; Chamberlain M; Berger M; Seager M; Davis RL
    Cancer Treat Rep; 1986 Nov; 70(11):1271-4. PubMed ID: 3021325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of the treatment of children with recurrent gliomas with lomustine and vincristine.
    Lefkowitz IB; Packer RJ; Sutton LN; Siegel KR; Bruce DA; Evans AE; Schut L
    Cancer; 1988 Mar; 61(5):896-902. PubMed ID: 3338054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temozolomide and oral VP-16 for children and young adults with recurrent or treatment-induced malignant gliomas.
    Korones DN; Smith A; Foreman N; Bouffet E
    Pediatr Blood Cancer; 2006 Jul; 47(1):37-41. PubMed ID: 16047359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chemotherapy of recurrent supratentorial malignant gliomas (phase II study)].
    Afra D; Sipos L; Vitanovics D
    Ideggyogy Sz; 2002 Jan; 55(1-2):38-44. PubMed ID: 12122942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of 6-thioguanine, capecitabine, and celecoxib with temozolomide or lomustine for recurrent high-grade glioma.
    Walbert T; Gilbert MR; Groves MD; Puduvalli VK; Yung WK; Conrad CA; Bobustuc GC; Colman H; Hsu SH; Bekele BN; Qiao W; Levin VA
    J Neurooncol; 2011 Apr; 102(2):273-80. PubMed ID: 20652724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Procarbazine and high-dose tamoxifen as a second-line regimen in recurrent high-grade gliomas: a phase II study.
    Brandes AA; Ermani M; Turazzi S; Scelzi E; Berti F; Amistà P; Rotilio A; Licata C; Fiorentino MV
    J Clin Oncol; 1999 Feb; 17(2):645-50. PubMed ID: 10080610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salvage chemotherapy with procarbazine and fotemustine combination in the treatment of temozolomide treated recurrent glioblastoma patients.
    Silvani A; Lamperti E; Gaviani P; Eoli M; Fiumani A; Salmaggi A; Falcone C; Filippini G; Botturi A; Boiardi A
    J Neurooncol; 2008 Apr; 87(2):143-51. PubMed ID: 17576523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined radiotherapy and chemotherapy with dibromodulcitol and CCNU in the postoperative treatment of malignant gliomas.
    Afra D; Kocsis B; Dobay J; Eckhardt S
    J Neurosurg; 1983 Jul; 59(1):106-10. PubMed ID: 6306179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of recurrent gliomas with eflornithine.
    Levin VA; Prados MD; Yung WK; Gleason MJ; Ictech S; Malec M
    J Natl Cancer Inst; 1992 Sep; 84(18):1432-7. PubMed ID: 1380989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.